$3.52
9.32% yesterday
Nasdaq, Aug 21, 10:14 pm CET

Applied DNA Sciences, Inc. Stock price

$3.52
-1.59 31.12% 1M
-114.23 97.01% 6M
-149.48 97.70% YTD
-1,548.98 99.77% 1Y
-55,646.48 99.99% 3Y
-139,496.48 100.00% 5Y
-1,931,996.48 100.00% 10Y
+2.92 486.67% 20Y
Nasdaq, Closing price Thu, Aug 21 2025
+0.30 9.32%

Key metrics

Basic
Market capitalization
$4.6m
Enterprise Value
$-2.3m
Net debt
positive
Cash
$6.8m
Shares outstanding
420.0k
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.2 | 0.8
EV/Sales
negative | negative
EV/FCF
0.2
P/B
0.4
Financial Health
Equity Ratio
71.5%
Return on Equity
-79.0%
ROCE
-117.0%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$3.8m | $5.4m
EBITDA
$-12.7m | -
EBIT
$-13.0m | $-11.9m
Net Income
$-46.2m | $-154.2m
Free Cash Flow
$-14.0m
Growth (TTM | estimate)
Revenue
-31.3% | 57.1%
EBITDA
4.6% | -
EBIT
9.6% | 15.1%
Net Income
-269.5% | -2,033.1%
Free Cash Flow
-15.1%
Margin (TTM | estimate)
Gross
40.8%
EBITDA
-333.9% | -
EBIT
-344.1%
Net
-1,218.5% | -2,861.3%
Free Cash Flow
-368.0%
More
EPS
$-390.7
FCF per Share
$-33.2
Short interest
13.5%
Employees
47
Rev per Employee
$70.0k
Show more

Is Applied DNA Sciences, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Applied DNA Sciences, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Applied DNA Sciences, Inc. forecast:

3x Hold
50%
3x Sell
50%

Analyst Opinions

6 Analysts have issued a Applied DNA Sciences, Inc. forecast:

Hold
50%
Sell
50%

Financial data from Applied DNA Sciences, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
3.79 3.79
31% 31%
100%
- Direct Costs 2.25 2.25
38% 38%
59%
1.55 1.55
18% 18%
41%
- Selling and Administrative Expenses 11 11
13% 13%
290%
- Research and Development Expense 3.61 3.61
0% 0%
95%
-13 -13
5% 5%
-334%
- Depreciation and Amortization 0.39 0.39
66% 66%
10%
EBIT (Operating Income) EBIT -13 -13
10% 10%
-344%
Net Profit -46 -46
270% 270%
-1,219%

In millions USD.

Don't miss a Thing! We will send you all news about Applied DNA Sciences, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Applied DNA Sciences, Inc. Stock News

Neutral
Accesswire
8 days ago
STONY BROOK, NY / ACCESS Newswire / August 14, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production solutions for the biopharmaceutical and diagnostics industries, today reported financial results for its third quarter of fiscal 2025 ended June 30, 2025. The Company's Form 10-Q for its fiscal third...
Neutral
Accesswire
29 days ago
STONY BROOK, NY / ACCESS Newswire / July 24, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in synthetic DNA manufacturing powered by scalable PCR platforms, today announced it received a seventh follow-on order valued at more than $600,000 for a multi-gram quantity of LineaDNA™. The follow-on order was placed by a global manufacturer of in vitro diag...
Neutral
Accesswire
about 2 months ago
STONY BROOK, NY / ACCESS Newswire / July 7, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (the "Company"), a leader in PCR-based DNA technologies, today announced that on July 2, 2025, it received written notice (the "Compliance Notice") from The Nasdaq Stock Market LLC ("Nasdaq") informing the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires that co...
More Applied DNA Sciences, Inc. News

Company Profile

Applied DNA Sciences, Inc. engages in the provision of security solutions. It offers molecular-based technology solutions and services that can help protect products, brands, supply chains, and intellectual property of companies, governments, and consumers from theft, counterfeiting, fraud, and diversion. Its products include the following brands: Applied DNA Sciences, SigNature, molecular tags, SigNature, T molecular tags, fiberTyping, DNAnet, digitalDNA, SigNify, BackTrac, Beacon, and CertainT. The company was founded in 1983 and is headquartered in Stony Brook, NY.

Head office United States
CEO James Hayward
Employees 47
Founded 1983
Website adnas.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today